MedTrace Logo

Prediction of Appearance of Late Cutaneous Side Effects After RadioTherapy

NCT03060226 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-12-21

No results posted yet for this study

Summary

Search for blood predictive marker (s) for cutaneous radiosensitivity

Conditions

  • Merkel Carcinoma
  • Radiotherapy Side Effect

Interventions

DIAGNOSTIC_TEST

blood sample

Search of blood predictive marker (s)

Sponsors & Collaborators

  • Centre Francois Baclesse

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-09
Primary Completion
2018-12-20
Completion
2018-12-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060226 on ClinicalTrials.gov